Jade Biosciences (JBIO) Cash from Operations (2020 - 2026)
Jade Biosciences posted quarterly Cash from Operations of 24100000.0 for Q1 2026, down 28.49% year-on-year from 33699396.15 in Q1 2025, and up 28.46% on a QoQ basis from 33689000.0 in Q4 2025.
Jade Biosciences (JBIO) has 7 years of Cash from Operations data on file, last reported at 24100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 28.49% year-over-year to 24100000.0; the trailing twelve-month figure through Mar 2026 stood at 100032000.0 (down 107.65% YoY), and the FY2025 full-year result was 94689000.0, down 33.0% from the prior year.
- Cash from Operations for Q1 2026 stood at 24100000.0, up from 33689000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 5661000.0 in Q1 2022 and bottomed at 33689000.0 in Q4 2025.
- The 5-year median for Cash from Operations is 15277000.0 (2023), against an average of 16736125.0.
- The widest annual swing landed in 2024, when Cash from Operations surged 56.43%; it then sank 224.9% in 2025.
- A 5-year view of Cash from Operations shows it stood at 14865000.0 in 2022, then advanced by 0.44% to 14800000.0 in 2023, then tumbled by 52.8% to 22614000.0 in 2024, then tumbled by 48.97% to 33689000.0 in 2025, then gained by 28.46% to 24100000.0 in 2026.
- The last three Cash from Operations figures came in at 24100000.0 (Q1 2026), 33689000.0 (Q4 2025), and 22100000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | -24.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.10 Mn |
| Mar 31, 2026 | -24.10 Mn |
| Dec 31, 2025 | -33.69 Mn |
| Dec 31, 2025 | -33.69 Mn |
| Sep 30, 2025 | -22.10 Mn |
| Sep 30, 2025 | -22.10 Mn |
| Jun 30, 2025 | -20.14 Mn |
| Jun 30, 2025 | -20.14 Mn |
| Mar 31, 2025 | -18.76 Mn |
| Mar 31, 2025 | -18.76 Mn |
| Dec 31, 2024 | -22.61 Mn |
| Dec 31, 2024 | -22.61 Mn |
| Sep 30, 2024 | -6.80 Mn |
| Sep 30, 2024 | -6.80 Mn |
| Mar 31, 2024 | -23.67 Mn |
| Mar 31, 2024 | -23.67 Mn |
| Dec 31, 2023 | -14.80 Mn |
| Dec 31, 2023 | -14.80 Mn |
| Sep 30, 2023 | -15.61 Mn |
| Sep 30, 2023 | -15.61 Mn |
| Jun 30, 2023 | -14.94 Mn |
| Jun 30, 2023 | -14.94 Mn |
| Mar 31, 2023 | -11.42 Mn |
| Mar 31, 2023 | -11.42 Mn |
| Dec 31, 2022 | -14.87 Mn |
| Dec 31, 2022 | -14.87 Mn |
| Sep 30, 2022 | -9.72 Mn |
| Sep 30, 2022 | -9.72 Mn |
| Jun 30, 2022 | -8.88 Mn |
| Jun 30, 2022 | -8.88 Mn |
| Mar 31, 2022 | -5.66 Mn |
| Mar 31, 2022 | -5.66 Mn |
| Dec 31, 2021 | -13.09 Mn |
| Dec 31, 2021 | -13.09 Mn |
| Sep 30, 2021 | -6.53 Mn |
| Sep 30, 2021 | -6.53 Mn |
| Jun 30, 2021 | -4.01 Mn |
| Jun 30, 2021 | -4.01 Mn |
| Mar 31, 2021 | -3.78 Mn |
| Mar 31, 2021 | -3.78 Mn |
| Dec 31, 2020 | -2.88 Mn |
| Dec 31, 2020 | -2.88 Mn |
| Sep 30, 2020 | -2.43 Mn |
| Sep 30, 2020 | -2.43 Mn |